ATE544472T1 - Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie - Google Patents

Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie

Info

Publication number
ATE544472T1
ATE544472T1 AT08022155T AT08022155T ATE544472T1 AT E544472 T1 ATE544472 T1 AT E544472T1 AT 08022155 T AT08022155 T AT 08022155T AT 08022155 T AT08022155 T AT 08022155T AT E544472 T1 ATE544472 T1 AT E544472T1
Authority
AT
Austria
Prior art keywords
calcium phosphate
nanoparticle formulations
photosensitizer
preferred
photosensitizers
Prior art date
Application number
AT08022155T
Other languages
English (en)
Inventor
Volker Albrecht
Burkhard Gitter
Susanna Graefe
Arno Wiehe
Matthias Epple
Janine Schwiertz
Ganesan Kathinvel
Original Assignee
Biolitec Ag
Univ Duisburg Essen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolitec Ag, Univ Duisburg Essen filed Critical Biolitec Ag
Application granted granted Critical
Publication of ATE544472T1 publication Critical patent/ATE544472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT08022155T 2008-12-19 2008-12-19 Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie ATE544472T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08022155A EP2198885B1 (de) 2008-12-19 2008-12-19 Kalziumphosphat-Nanopartikel als Farbstoffträger für die photodynamische Therapie

Publications (1)

Publication Number Publication Date
ATE544472T1 true ATE544472T1 (de) 2012-02-15

Family

ID=40677783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08022155T ATE544472T1 (de) 2008-12-19 2008-12-19 Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie

Country Status (7)

Country Link
US (1) US8956648B2 (de)
EP (1) EP2198885B1 (de)
JP (1) JP5138818B2 (de)
CN (1) CN102256622B (de)
AT (1) ATE544472T1 (de)
ES (1) ES2381022T3 (de)
WO (1) WO2010078941A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010025476B4 (de) * 2010-06-29 2014-04-30 Universität des Saarlandes Komplexe mit Polystyrolsulfonat
WO2012145801A1 (en) * 2011-04-29 2012-11-01 Jagat Rakesh Kanwar Nanoparticle
WO2013009701A2 (en) 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
WO2014123935A1 (en) * 2013-02-05 2014-08-14 1Globe Health Institute Llc Biodegradable and clinically-compatible nanop articles as drug delivery carriers
CN103202316A (zh) * 2013-03-06 2013-07-17 安徽大学 一种具有抑菌功能的吩噻嗪衍生物/银纳米复合材料及其制备方法
US20160235708A1 (en) * 2013-10-04 2016-08-18 Sanjay Banerji Topical pigmentory composition
KR101567717B1 (ko) 2014-07-24 2015-11-10 가톨릭대학교 산학협력단 칼슘 이온 및 친수성 음이온성 광민감제를 이용한 나노복합체의 제조방법 및 상기 나노복합체를 이용한 약물전달체
KR101622031B1 (ko) * 2014-07-25 2016-05-19 경희대학교 산학협력단 광감작제 담지 탄산칼슘 복합 나노입자, 이의 제조방법 및 이를 포함하는 초음파 조영 및 광역학 치료용 조성물
JP2017537981A (ja) * 2014-12-09 2017-12-21 ベルモント ユニバーシティ リン酸カルシウムナノ粒子封入医薬用半固体ゲル
AU2016365412B2 (en) 2015-12-03 2022-05-19 Amrita Vishwa Vidyapeetham Radio-wave responsive doped nanoparticles for image-guided therapeutics
CN105954268B (zh) * 2016-04-22 2019-01-11 华南师范大学 一种基于四氧化三铁纳米簇催化信号放大的可视化检测传感器及其构建与应用
US20200181026A1 (en) * 2016-06-30 2020-06-11 Sofsera Corporation Calcium phosphate sintered body particles and method for producing same
EP3551034A1 (de) * 2016-12-07 2019-10-16 Progenity, Inc. Verfahren, vorrichtungen und systeme zur detektion des magen-darm-trakts
WO2019028250A1 (en) * 2017-08-02 2019-02-07 The University Of Chicago NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF
CA3143430A1 (en) * 2019-06-14 2020-12-17 Universidade De Coimbra Small cationic ortho-5,15-di-heteroaryl-porphyrins derivatives and their applications in photoinactivation of microorganisms
EP3789760A1 (de) * 2019-09-05 2021-03-10 PreSens Precision Sensing GmbH Kohlendioxidgassensor
KR102236212B1 (ko) 2019-11-13 2021-04-05 주식회사 메가젠임플란트 골조직 광열치료용 이중층 구조의 복합 멤브레인 및 그 제조방법
CN111973573B (zh) * 2020-08-04 2022-10-18 中山大学附属第七医院(深圳) 一种磷酸钙纳米颗粒及其制备方法和应用
CN115073520B (zh) * 2022-06-15 2026-02-24 上海科技大学 荧光分子、其磷酸钙纳米粒以及它们的制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7455858B2 (en) 2002-05-16 2008-11-25 Qlt Inc. Compositions and methods for delivery of photosensitive drugs
JP2008524203A (ja) * 2004-12-17 2008-07-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 分子イメージングのためのターゲティング剤
US20070218049A1 (en) 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same
US8207211B2 (en) * 2005-02-28 2012-06-26 The General Hospital Corporation Photosensitizers for targeted photodynamic therapy
DE102005016873A1 (de) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
US20080241256A1 (en) 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles
US20100323022A1 (en) * 2008-02-07 2010-12-23 Kuraray Medical Inc. Calcium phosphate composition and process for production thereof

Also Published As

Publication number Publication date
US8956648B2 (en) 2015-02-17
EP2198885B1 (de) 2012-02-08
WO2010078941A1 (en) 2010-07-15
EP2198885A1 (de) 2010-06-23
CN102256622A (zh) 2011-11-23
US20110257586A1 (en) 2011-10-20
JP2012512817A (ja) 2012-06-07
JP5138818B2 (ja) 2013-02-06
CN102256622B (zh) 2014-10-29
ES2381022T3 (es) 2012-05-22

Similar Documents

Publication Publication Date Title
Hamblin Fullerenes as photosensitizers in photodynamic therapy: pros and cons
Qi et al. Novel nanomaterial-based antibacterial photodynamic therapies to combat oral bacterial biofilms and infectious diseases
Nguyen et al. Organic photosensitizers for antimicrobial phototherapy
Kustov et al. Synthesis and investigation of water-soluble chlorophyll pigments for antimicrobial photodynamic therapy
Lima et al. Photodynamic therapy: from the basics to the current progress of N-heterocyclic-bearing dyes as effective photosensitizers
Kashef et al. Advances in antimicrobial photodynamic inactivation at the nanoscale
Kawczyk-Krupka et al. Photodynamic therapy as an alternative to antibiotic therapy for the treatment of infected leg ulcers
Hak et al. A review of advanced nanoformulations in phototherapy for cancer therapeutics
Hong et al. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials
Zhou et al. Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy
Huang et al. Functionalized fullerenes in photodynamic therapy
Tang et al. Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness
Hamblin Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes
Hamblin et al. Nanotechnology for photodynamic therapy: A perspective from the laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School
Lismont et al. Metal‐organic framework nanoparticles in photodynamic therapy: current status and perspectives
Ai et al. Recent advances of light-mediated theranostics
Sekkat et al. Like a bolt from the blue: phthalocyanines in biomedical optics
Hamblin Upconversion in photodynamic therapy: plumbing the depths
Maisch A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment
Yan et al. Antimicrobial photodynamic therapy for the remote eradication of bacteria
Kostron et al. Photodynamic medicine: From bench to clinic
Robinson‐Duggon et al. Potential applications of cucurbit [n] urils inclusion complexes in photodynamic therapy
ES2310521T3 (es) Medicamentos topicos mejorados y metodos que permiten el tratamiento de enfermedades de manera fotodinamica.
Xie et al. Recent Advances in Tetrakis (4‐Carboxyphenyl) Porphyrin‐Based Nanocomposites for Tumor Therapy
De Freitas et al. Antimicrobial photoinactivation with functionalized fullerenes